Joelle Bailey
Psychiatric/Mental Health · Colorado Springs, CONPI 1528580487
Payments from drug & device makers
Across 107 payments — averaging $20.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$505
- Neurocrine Biosciences, Inc.$388
- Alkermes, Inc.$279
- Teva Pharmaceuticals USA, Inc.$205
- Vanda Pharmaceuticals Inc.$184
- Takeda Pharmaceuticals U.S.A., Inc.$90
- plus $555 from 12 others
What the payments were for
- Food & beverage$2,206100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 27 | $505 |
| Neurocrine Biosciences, Inc. | 30 | $388 |
| Alkermes, Inc. | 4 | $279 |
| Teva Pharmaceuticals USA, Inc. | 4 | $205 |
| Vanda Pharmaceuticals Inc. | 7 | $184 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $90 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $82 |
| Tempus AI, Inc | 3 | $73 |
| Eisai Inc. | 4 | $72 |
| Otsuka America Pharmaceutical, Inc. | 4 | $69 |
| Jazz Pharmaceuticals Inc. | 4 | $62 |
| Lundbeck LLC | 3 | $53 |
| Avanir Pharmaceuticals, Inc. | 2 | $37 |
| Sunovion Pharmaceuticals Inc. | 2 | $31 |
| Bausch Health US, LLC | 1 | $21 |
| Corium, LLC | 1 | $20 |
| Alfasigma USA, Inc. | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,206 in reported general payments places this provider in the 85th percentile of 873 psychiatric/mental health providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 15 | $467 |
| Prazosin Hcl | 12 | $291 |
| Clonazepam | 15 | $238 |
| Quetiapine Fumarate | 19 | $174 |
| Sertraline Hcl | 16 | $64 |
| Trazodone Hcl | 11 | $53 |
| Alprazolam | 24 | $32 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Colorado Springs
- Mark JankelowColorado Springs$287K
- Cristi BundukamaraColorado Springs$230K
- Jennie StormesColorado Springs$12K
- Kimberly SmithColorado Springs$9K
- Lewis SwarthoutColorado Springs$7K
- Ann ChartrandColorado Springs$7K
- Kristin MagnusonColorado Springs$7K
- Shannon GravesColorado Springs$6K
- Alison BakerColorado Springs$6K
- Patricia BursnallColorado Springs$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.